Source: Annual Congress 2007 - Pulmonary hypertension in the clinic
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Montani, L. Achouh, A. Rabiller, R. Haque, P. Dorfmüller, F. Capron, O. Sitbon, X. Jaïs, G. Simonneau, M. Humbert (Clamart, Paris, France). Pulmonary veno-occlusive disease: clinical, functional and hemodynamic characteristics. Eur Respir J 2007; 30: Suppl. 51, 3282

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary veno-occlusive disease: clinical, functional, radiologic and hemodynamic characteristics and outcome of 24 cases confirmed by histology Source: Annual Congress 2008 - Pulmonary hypertension II Year: 2008 Pulmonary hemodynamics and clinical manifestations of COPD patients: is there a relationship? Source: Virtual Congress 2020 – Investigations of COPD Year: 2020 Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics Source: Eur Respir J 2005; 25: 783-788 Year: 2005 Outcome of pulmonary thromboendarterectomy in chronic thromboembolic disease with normal hemodynamic: is it time to change the definition of CTEPH Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension Year: 2019 Pulmonary hypertension and pulmonary vascular disease: course report Source: Breathe, 14 (1) e4; 10.1183/20734735.019917 Year: 2018 Idiopathic and systemic sclerosis-associated PAH: A comprehensive haemodynamic and radiological comparison Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology Year: 2016 Clinical features of pulmonary hypertension Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease Year: 2018 Clinical features of pulmonary hypertension Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2017 Clinical features of pulmonary hypertension Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2014 Clinical characteristics, haemodynamics, and survival in patients with combined pulmonary fibrosis and emphysema and associated pulmonary hypertension Source: Annual Congress 2008 - Pulmonary vascular medicine Year: 2008 Echocardiographic assessment of cardiac function in patients with chronic obstructive pulmonary disease Source: International Congress 2015 – COPD: interesting notes Year: 2015 Hemodynamic assessment of patients with pulmonary hypertension due to lung disease and/or hypoxia Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II Year: 2013 Pulmonary hypertension associated with sarcoidosis Source: Eur Respir Mon 2012; 57: 166-181 Year: 2012 Pulmonary veno-occlusive disease Source: Eur Respir J 2016; 47:1518-1534 Year: 2016 The use of genetic testing in an atypical presentation of pulmonary veno-occlusive disease Source: Virtual Congress 2020 – Pulmonary vascular diseases Year: 2020 Characteristics and outcomes of heritable pulmonary veno-occlusive disease due to EIF2AK4 mutations Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH Year: 2015 Pulmonary arterial hypertension associated with sarcoidosis (BBS-PAH): mechanisms, hemodynamics and prognosis Source: Eur Respir J 2002; 20: Suppl. 38, 371s Year: 2002 Pulmonary veno-occlusive disease misdiagnosed as idiopathic pulmonary arterial hypertension Source: Eur Respir Rev 2009; 18: 177-180 Year: 2009 Hemodynamic and clinical relevance of “borderline pulmonary hypertension“ Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013